Portfolio
Aspect Analytics
Digital HealthBringing spatial multi-omics data together
Aspect Analytics
Bingli
Digital HealthThe smartest medical interview
Bingli
BlueBee
Digital HealthCutting-edge digital technology to drastically accelerate DNA processing and analysis.
BlueBee
Cartagenia
Digital HealthSoftware solutions for genetic diagnosis
Cartagenia
Confo Therapeutics
Pharma & BiotechStabilize, target, discover and transform
Confo Therapeutics
DEO.care
Digital HealthData-Driven Efficiency for the Operating Room
DEO.care
Diagenode
DiagnosticsLeading molecular diagnostics
Diagenode
FEops
Digital HealthTransforming cardiac images into digital twins
FEops
Icometrix
Digital HealthTransforming patient care through AI-driven imaging
Icometrix
Indigo Diabetes
Digital HealthGlucose-monitoring sensors
Indigo Diabetes
Mainstay Medical
Medical DevicesRehabilitative treatment for severe low back pain
Mainstay Medical
Minze
Digital HealthUroflowmetry and bladder diaries reinvented
Minze
Neotiv
Digital HealthEnabling cognitive health
Neotiv
Noona
Digital HealthEngaging cancer patients in their care
Noona
Ogeda
Pharma & BiotechClinical-stage drug discovery
Ogeda
Oska Health
Digital HealthPersonal health & nutrition coaching
Oska Health
Sequana Medical
Medical DevicesInnovative treatments for fluid overload
Sequana Medical
Thryve
Digital HealthShaping the Future of Personalized Health
Thryve
Xyall
Medical DevicesThe world's first fully automated tissue dissection solution
Xyall
iSTAR Medical
Medical DevicesImplants for patients with glaucoma
iSTAR Medical
Sector
Medical Devices
Headquarters
Belgium
Portfolio entry
2013: Capricorn Healthtech Fund I
Implants for patients with glaucoma
iSTAR Medical aims to improve the lives of patients suffering from eye diseases by developing innovative minimally invasive ophthalmic implants made from STAR® Biomaterial.
It is estimated that globally about 80 million, mainly elderly people, suffer from glaucoma. Glaucoma is the second-leading cause of blindness and often a result of lack of therapy compliance. Funding innovations that reduce the therapy burden on patients lies at the heart of the fund’s strategy.
